<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mpath ids='MPATH_167'>Intestinal metaplasia</z:mpath> is a prerequisite criterion for the diagnosis of Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> and the sole columnar esophageal lining associated with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>It is recognized by the presence of goblet cells, but columnar non-goblet elements, producing gastric or intestinal proteins, are the prevalent cell population </plain></SENT>
<SENT sid="2" pm="."><plain>The cellular <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> is well documented but the relationship between the distinct cell subtypes and <z:hpo ids='HP_0002664'>neoplasia</z:hpo> is unclear </plain></SENT>
<SENT sid="3" pm="."><plain>Our aim was to clarify the relationship between the different metaplastic populations and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in order to investigate putative markers for risk stratification of Barrett's patients </plain></SENT>
<SENT sid="4" pm="."><plain>We studied 46 columnar-lined esophageal segments, 15 with associated <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>The presence of the gastric, MUC5AC and MUC6, and the intestinal, MUC2, proteins was evaluated in metaplastic (columnar and goblet) and neoplastic cells </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:hpo ids='HP_0002664'>neoplasia</z:hpo> MUC5AC and MUC6 were detected in 100% and 86.6% of the cases, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:mpath ids='MPATH_160'>metaplasia</z:mpath> there were no differences in MUC5AC and MUC6 immunoreactivity, between cases with and without associated <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, except for goblet elements producing MUC6 that were exclusive of <z:mpath ids='MPATH_160'>metaplasia</z:mpath> adjacent to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (P &lt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>MUC2 was present in 86.6% of the <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>In <z:mpath ids='MPATH_160'>metaplasia</z:mpath> it was restricted to Barrett's cases and was more frequent in areas with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Columnar-lined esophagus</z:e> without <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> did not express MUC2 </plain></SENT>
<SENT sid="11" pm="."><plain>Our study suggests a relationship between the metaplastic population with gastric phenotype and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, and points to the involvement of columnar as well as goblet elements in <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>The association between goblet cells aberrantly producing MUC6 and the presence of <z:hpo ids='HP_0002664'>neoplasia</z:hpo> suggests they may be useful for risk stratification </plain></SENT>
</text></document>